News > Expanding Pathoplexus: Dengue and Yellow Fever Virus added
By the Pathoplexus Team - 11 March 2026
Today Pathoplexus is launching support for yellow fever virus and dengue virus sequence sharing. Yellow fever virus and dengue virus (formally Orthoflavivirus flavi and Orthoflavivirus denguei, respectively) are both arboviruses transmitted by Aedes mosquitos. Yellow fever virus causes yellow fever, which is endemic in Africa and South America. Dengue fever — colloquially known as break-bone fever — occurs more broadly in tropical and subtropical climates around the world.
Together, these viruses are estimated to account for over 400 million infections and 43,000 to 94,000 deaths per year. Particularly concerning is the fact that global infections for dengue are rising steeply, and that the virus is spreading to new areas. By facilitating open sharing of yellow fever virus and dengue virus sequences, Pathoplexus seeks to support research and empower public health responses to these arboviruses.
Dr Anderson Brito, a research scientist at Instituto Todas pela Saude (ITpS), Brazil, and member of the Pathoplexus Executive Board, received expressions of interest from the community about adding dengue and yellow fever virus. He commented, “Integrating dengue and yellow fever virus into Pathoplexus means providing endemic countries a transparent, equitable way to share data under terms of use that protect generators’ rights. This creates a collaborative ecosystem where data can safely be contributed for the global public good, fostering the timely genomic surveillance essential for public health.”
Given the varied hosts for these species, we require the submission of the host scientific name metadata field for yellow fever virus and dengue (alongside our normally required fields of sample ID, country of collection, and date).
We are adding this as samples from these viruses are often obtained from vectors, such as mosquitos, and infected animals, making this field important for analysis and surveillance.
The addition of these two arboviruses was resolved by our Executive Board after very strong expressions of community support.
Pathoplexus is grateful to have received a $500,000 grant from Kanro, the philanthropic initiative supported by Vitalik Buterin. This contribution will help sustain and expand our open infrastructure that enables transparent and equitable sharing of pathogen genomic data. We are deeply thankful for the trust placed in our mission.
Pathoplexus now hosts over 10,400 directly-submitted sequences. Since our last update in November 2025, over 1,500 new sequences have been directly submitted across six pathogens, from labs in Africa, Europe, Asia, and the Americas.
Our first direct upload of measles virus sequences to Pathoplexus came from Senegal. Dr Idrissa Dieng, a research scientist from Institute Pasteur de Dakar and Deputy Head of the Measles and Rubella National Reference Center, told us:
“Pathoplexus represents a new generation of genomic data platforms, one that balances rapid data sharing with recognition of the scientists generating the data. The measles sequences we uploaded are the first full-genome measles sequences generated from Senegal, marking an important milestone for genomic surveillance in the country. By sharing them through Pathoplexus, we are strengthening global measles monitoring while ensuring that African-generated data are visible, valued, and integrated into international public health action.”
A summary of our new uploads include:
593 new RSV-A sequences, from Respiratory Virus Unit, Hospital Universitari Vall d’Hebron, Barcelona, Spain (169); Institute of Virology Düsseldorf, Germany (150); WHO Influenza Collaborating Center, Australia (95, including samples from Sri Lanka); Pathogen Omics and Epidemiology (PEO) Group, KEMRI Wellcome-Trust, Kenya (87); NVRL Ireland (71); Laboratorio de Salud Publica, Universidad Nacional de La Plata, Argentina (13); and UMCU_RSV, Netherlands (8, including samples from South Africa and Argentina)
445 new RSV-B sequences, from WHO Influenza Collaborating Center, Australia (141, including samples from Sri Lanka); Respiratory Virus Unit, Hospital Universitari Vall d’Hebron, Barcelona, Spain (84); NVRL Ireland (79); Institute of Virology Düsseldorf, Germany (63); Pathogen Omics and Epidemiology (PEO) Group, KEMRI Wellcome-Trust, Kenya (52); UMCU_RSV, Netherlands (18, including samples from South Africa and Argentina); GEVOP, ILMD-FioCruz, Instituto Todos pela Saúde, Brazil (6); and Laboratorio de Salud Publica, Universidad Nacional de La Plata, Argentina (2).
357 new measles sequences, from Decode, Senegal (2) - the first direct measles submission to Pathoplexus; Center for Vaccines & Immunology, NICD, South Africa (28); and PHAC-NML-MMR, Canada (327)
130 new mpox sequences, from Genomics and Bioinformatics Unit @ INSA, Portugal (83); Épidémiologie et Physiopathologie des Virus Oncogènes, Central African Republic (26); NVRL Ireland (6); KRL_ITM, Belgium (5); FEEVIR Project, Angola (3) - the first mpox sequences shared from Angola, as far as we’re aware; Pathogen Omics and Epidemiology (PEO) Group, KEMRI Wellcome-Trust, Kenya (3); MCL, ICMR-NIV Pune, India (2) - first mpox sequences uploaded to Pathoplexus from India; and SP_NML_PHAC, Canada (2)
21 new HMPV sequences, from Centre for Epidemic Response and Innovation (CERI), South Africa
14 new West Nile virus sequences, from Unité des Virus Émergents, Aix-Marseille Université, France
As well as directly uploaded sequences, we also ingest data from INSDC databases, ensuring users can access all openly available sequences via Pathoplexus.
Pathoplexus is dedicated to serving the pathogen community, and as such we aim to be active participants in initiatives that help us connect with and better understand the needs of our users (and potential users!).
Pathoplexus is grateful to have been included as a ‘Relevant Stakeholder’ for the ongoing WHO Pathogen Access and Benefits (PABS) Intergovernmental Working Group (IGWG) negotiations. This status allows Pathoplexus to participate directly in some of the sessions, and additionally be available to interact with Member States to answer questions about pathogen genomic data sharing and share our experience and success in running an ‘open-access, restricted-use’ system.
In the last three months, we’ve introduced several improvements across datasets, ingestion pipelines, mutation search, and submission workflows. Below is a summary of the latest updates.
We now also attempt to align sequences to reference genomes using the reverse complement of the provided sequence, if the initial alignment fails. This has significantly increased the number of successfully aligned sequences ingested from the INSDC. Newly aligned sequences include:
We now ingest INSDC measles sequences from a higher taxonomic level: Morbillivirus hominis. This change allows us to mirror additional data and significantly increases the number of available sequences. This update was prompted by Jover Lee, who noticed that the measles taxon ID needed to be updated.
A new nextclade dataset for Crimean-Congo Hemorrhagic Fever (CCHF) including lineage information for the S segment is now used for processing of CCHF sequences.
We have adjusted how multi-segmented virus data is uploaded.
Now, you can include an additional metadata field called fastaIds, with the identifiers in the fasta file of all of the sequences to be linked to a specific metadata entry.
The field contains a space-separated list of FASTA identifiers, for example:
seq_12_A seq_12_B
Pathoplexus will automatically assign each sequence to the segment that it aligns to, simplifying the submission process for segmented pathogens. Read more about sequence submission here: https://pathoplexus.org/docs/how-to/upload-sequences.
Mutation search has been redesigned for segmented viruses. Nucleotide and amino acid mutation search now operates at the segment level. Users no longer need to append the segment name when querying nucleotide mutations. This makes mutation queries simpler and more intuitive.

We improved the group management interface to make collaboration easier: Users are now warned if a group name is already in use, and are shown ways to contact existing groups to request to join them. It is now also easier to discover existing groups. These improvements help avoid duplicate groups and streamline collaboration.

Remember that you can always check our minutes from General Assemblies and Executive Board meetings, as well as Executive Board resolutions.